Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Cabrera JS"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lopez-Pascual A; Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain.; Instituto de Investigaciones Sanitarias de Navarra IdiSNA, Pamplona, Spain., Russo-Cabrera JS; Immunology and Immunotherapy Program, CIMA, CCUN, University of Navarra, Pamplona, Spain., Ardaiz N; Immunology and Immunotherapy Program, CIMA, CCUN, University of Navarra, Pamplona, Spain., Palmer T; Moderna Inc, Cambridge, Massachusetts, U.S.A., Graham AR; Moderna Inc, Cambridge, Massachusetts, U.S.A., Uriarte I; Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain.; CIBERehd, Madrid, Spain., Gomar C; Immunology and Immunotherapy Program, CIMA, CCUN, University of Navarra, Pamplona, Spain., Ruiz-Guillamon D; Immunology and Immunotherapy Program, CIMA, CCUN, University of Navarra, Pamplona, Spain., Latasa MU; Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain.; CIBERehd, Madrid, Spain., Arechederra M; Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain.; Instituto de Investigaciones Sanitarias de Navarra IdiSNA, Pamplona, Spain.; CIBERehd, Madrid, Spain., Fontanellas A; Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain.; Instituto de Investigaciones Sanitarias de Navarra IdiSNA, Pamplona, Spain.; CIBERehd, Madrid, Spain., Monte MJ; CIBERehd, Madrid, Spain.; Experimental Hepatology and Drug Targeting (HEVEPHARM), University of Salamanca, IBSAL, Salamanca, Spain., Marin JJG; CIBERehd, Madrid, Spain.; Experimental Hepatology and Drug Targeting (HEVEPHARM), University of Salamanca, IBSAL, Salamanca, Spain., Berasain C; Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain.; CIBERehd, Madrid, Spain., Del Rio CL; Moderna Inc, Cambridge, Massachusetts, U.S.A., Fernandez-Barrena MG; Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain.; Instituto de Investigaciones Sanitarias de Navarra IdiSNA, Pamplona, Spain.; CIBERehd, Madrid, Spain., Martini PGV; Moderna Inc, Cambridge, Massachusetts, U.S.A., Schultz JR; Moderna Inc, Cambridge, Massachusetts, U.S.A., Berraondo P; Immunology and Immunotherapy Program, CIMA, CCUN, University of Navarra, Pamplona, Spain.; CIBERonc, Madrid, Spain., Avila MA; Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain.; Instituto de Investigaciones Sanitarias de Navarra IdiSNA, Pamplona, Spain.; CIBERehd, Madrid, Spain.
Publikováno v:
Clinical science (London, England : 1979) [Clin Sci (Lond)] 2024 Oct 16; Vol. 138 (20), pp. 1265-1284.
Autor:
Ocaña-Cabrera JS; Research Unit of Epidemiology and Risk Analysis Applied to Veterinary Sciences (UREAR-ULiège), Fundamental and Applied Research for Animal and Health (FARAH) Center, Department of Infections and Parasitic Diseases, Faculty of Veterinary Medicine, University of Liege, 4000 Liège, Belgium., Martin-Solano S; Grupo de Investigación en Sanidad Animal y Humana (GISAH), Carrera de Ingeniería en Biotecnología, Departamento de Ciencias de la Vida y de la Agricultura, Universidad de las Fuerzas Armadas ESPE, P.O. Box 171-5-231, Sangolquí 171103, Ecuador., Saegerman C; Research Unit of Epidemiology and Risk Analysis Applied to Veterinary Sciences (UREAR-ULiège), Fundamental and Applied Research for Animal and Health (FARAH) Center, Department of Infections and Parasitic Diseases, Faculty of Veterinary Medicine, University of Liege, 4000 Liège, Belgium.
Publikováno v:
Insects [Insects] 2024 Sep 19; Vol. 15 (9). Date of Electronic Publication: 2024 Sep 19.
Autor:
Cabrera JS; Electrophysiology Department, Fundación Cardio Infantil, Bogota, Colombia.; Medicine School department, Universidad De La Sabana, Bogota, Colombia., Tapias C; Electrophysiology Department, Fundación Cardio Infantil, Bogota, Colombia.; Medicine School department, Universidad De La Sabana, Bogota, Colombia., Adams C; Electrophysiology Department, Fundación Cardio Infantil, Bogota, Colombia.; Medicine School department, Universidad De La Sabana, Bogota, Colombia., Hernandez B; Electrophysiology Department, Fundación Cardio Infantil, Bogota, Colombia.; Medicine School department, Universidad De La Sabana, Bogota, Colombia., Bautista W; Electrophysiology Department, Fundación Cardio Infantil, Bogota, Colombia.; Medicine School department, Universidad De La Sabana, Bogota, Colombia., Stozitzky V; Electrophysiology Department, Fundación Cardio Infantil, Bogota, Colombia., Restrepo AJ; Florida Electrophysiology Associates, Atlantis, Florida, USA.; Medicine School department, University of Maryland, Baltimore, Maryland, USA., Saenz L; Electrophysiology Department, Fundación Cardio Infantil, Bogota, Colombia.; Medicine School department, Universidad De La Sabana, Bogota, Colombia.
Publikováno v:
Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2024 Jul; Vol. 35 (7), pp. 1393-1400. Date of Electronic Publication: 2024 May 13.
Autor:
Rivera Boadla ME; Internal Medicine, Maimonides Medical Center, Brooklyn, USA., Sharma NR; Internal Medicine, Maimonides Medical Center, Brooklyn, USA.; Medicine, Manipal College of Medical Science, Pokhara, NPL., Gulati A; Cardiology, Icahn School of Medicine at Mount Sinai, New York, USA., Khurana S; Radiology, Columbia University, Brooklyn, USA., Khan MH; Internal Medicine, Maimonides Medical Center, Brooklyn, USA., Batool A; Internal Medicine, Jinnah Hospital, Allama Iqbal Medical College (AIMC), Lahore, PAK., Farooqui AA; Internal Medicine, Maimonides Medical Center, Brooklyn, USA., Cabrera JS; Medicine, Universidad Tecnológica Centroamericana (UNITEC), Tegucigalpa, HND., Aparicio Recarte T; Medicine, Universidad Nacional Autonoma de Honduras, San Pedro Sula, HND., Hashmi AT; Cardiology, Maimonides Medical Center, Brooklyn, USA.
Publikováno v:
Cureus [Cureus] 2024 Apr 27; Vol. 16 (4), pp. e59155. Date of Electronic Publication: 2024 Apr 27 (Print Publication: 2024).
Autor:
Gomar C; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Di Trani CA; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Bella A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Arrizabalaga L; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Gonzalez-Gomariz J; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Fernandez-Sendin M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Alvarez M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Russo-Cabrera JS; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Ardaiz N; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Aranda F; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Schippers T; Hookipa Pharma Inc, New York, New York, USA., Quintero M; Highlight Therapeutics, Valencia, Spain., Melero I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Departments of Immunology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Orlinger KK; Hookipa Pharma Inc, New York, New York, USA., Lauterbach H; Hookipa Pharma Inc, New York, New York, USA., Berraondo P; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain pberraondol@unav.es.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Apr 16; Vol. 12 (4). Date of Electronic Publication: 2024 Apr 16.
Autor:
Arrizabalaga L; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Russo-Cabrera JS; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Belsúe V; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Berraondo P; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Melero I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Department of Oncology and Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain; Nuffield Department of Medicine and Oxford Center for Immuno-Oncology, University of Oxford, Oxford, United Kingdom., Aranda F; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain. Electronic address: faranda@unav.es.
Publikováno v:
Methods in cell biology [Methods Cell Biol] 2024; Vol. 189, pp. 55-69. Date of Electronic Publication: 2024 Jun 15.
Autor:
Bella Á; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Arrizabalaga L; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Di Trani CA; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Gonzalez-Gomariz J; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Gomar C; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Russo-Cabrera JS; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Olivera I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Cirella A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Fernandez-Sendin M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Alvarez M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Teijeira A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Atay C; Bavarian Nordic GmbH, Martinsried, Germany., Medina-Echeverz J; Bavarian Nordic GmbH, Martinsried, Germany., Hinterberger M; Bavarian Nordic GmbH, Martinsried, Germany., Hochrein H; Bavarian Nordic GmbH, Martinsried, Germany., Melero I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Department of Oncology and Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain.; Nuffield Department of Medicine and Oxford Center for Immuno-Oncology, University of Oxford, Oxford, UK., Berraondo P; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Aranda F; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain faranda@unav.es.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Nov; Vol. 11 (11).
Autor:
Di Trani CA; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Cirella A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Arrizabalaga L; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Alvarez M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain., Bella Á; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Fernandez-Sendin M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Russo-Cabrera JS; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Gomar C; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Ardaiz N; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Teijeira A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain., Bolaños E; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., González-Gomariz J; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Otano I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Aranda F; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Palencia B; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Segués A; Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, EH9 3FL Edinburgh, UK.; Faculty of Veterinary Medicine, Department of Infectious Diseases and Immunology, Utrecht University, 3584 CS Utrecht, The Netherlands., Huang S; Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, EH9 3FL Edinburgh, UK.; Faculty of Veterinary Medicine, Department of Infectious Diseases and Immunology, Utrecht University, 3584 CS Utrecht, The Netherlands., van Duijnhoven SMJ; ImmunoPrecise Antibodies Ltd., 5349 AB Oss, The Netherlands., van Elsas A; Third Rock Ventures, San Francisco, CA 94158, USA., Melero I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain.; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Berraondo P; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain.
Publikováno v:
Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2023 Jul 19; Vol. 33, pp. 599-616. Date of Electronic Publication: 2023 Jul 19 (Print Publication: 2023).
Autor:
Di Trani CA; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Cirella A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Arrizabalaga L; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Bella Á; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Fernandez-Sendin M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Russo-Cabrera JS; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Gomar C; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Olivera I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Bolaños E; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., González-Gomariz J; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Álvarez M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain., Etxeberria I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Palencia B; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Teijeira Á; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain., Melero I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain.; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Berraondo P; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain., Aranda F; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2022 Dec 15; Vol. 12 (1), pp. 2147317. Date of Electronic Publication: 2022 Dec 15 (Print Publication: 2023).